Literature DB >> 26875541

Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.

Christopher R Ellis1, Deanna I Dickerman2, Jodi M Orton1, Sohail Hassan3, Eric D Good4, Toshimasa Okabe5, John A Andriulli6, Kara J Quan7, Arnold J Greenspon8.   

Abstract

BACKGROUND: Cardiac resynchronization defibrillator (CRT-D) devices improve survival for New York Heart Association classes II-IV systolic heart failure patients with QRS > 120 ms and left ventricular ejection fraction < 35%. A limitation of 100% CRT pacing is excess battery depletion and pulse generator (PG) replacement compared to VVI or dual-chamber systems. Ampere hour (Ah) measures PG battery capacity and may predict CRT-D device longevity.
METHODS: We performed a multicenter retrospective study of all CRT-D devices implanted at our centers from August 1, 2008 to December 31, 2010. Analysis was performed for survival to elective replacement indicator (ERI) between 1.0 Ah, 1.4 Ah, and 2.0 Ah devices, per manufacturers' specifications.
RESULTS: One thousand three hundred and two patients were studied through December 31, 2014. Patients were followed for an average of 3.0 ± 1.3 years (794 1.0 Ah, 322 2.0 Ah, and 186 1.4 Ah devices under study). CRT-D generator ERI occurred in 13.5% of 1.0 Ah systems (107 out of 794), versus 3.8% in 1.4 Ah (seven out of 186), and 0.3% in 2.0 Ah devices (one out of 322) over mean follow-up of 3.0 years. Odds ratio (OR) for reaching ERI with 1.0 Ah device versus 1.4 Ah or 2.0 Ah was 9.73, P < 0.0001. Univariate predictors for ERI included 1.0 Ah device and LV pacing output >3V @ 1 ms (OR: 3.74, P < 0.001). LV impedance >1,000 ohms predicted improved device survival (OR: 0.38, P = 0.0025).
CONCLUSIONS: CRT-D battery capacity measured by Ah is a strong predictor of survival to ERI for modern systems. Further study on cost and morbidity associated with early PG change in 1.0 Ah systems is warranted. ©2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ampere hour; ICD; battery; defibrillator; longevity; resynchronization

Mesh:

Year:  2016        PMID: 26875541     DOI: 10.1111/pace.12831

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

Review 1.  ENDURALIFE-Powered Cardiac Resynchronisation Therapy Defibrillator Devices for Treating Heart Failure: A NICE Medical Technology Guidance.

Authors:  James Michael Evans; Andrew Cleves; Helen Morgan; Liesl Millar; Grace Carolan-Rees
Journal:  Appl Health Econ Health Policy       Date:  2018-04       Impact factor: 2.561

2.  The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.

Authors:  Maurizio Landolina; Giovanni Morani; Antonio Curnis; Antonello Vado; Antonio D'Onofrio; Valter Bianchi; Giuseppe Stabile; Martino Crosato; Barbara Petracci; Carlo Ceriotti; Luca Bontempi; Martina Morosato; Gian Paolo Ballari; Maurizio Gasparini
Journal:  Europace       Date:  2017-08-01       Impact factor: 5.214

3.  Longevity decoded: Insights from power consumption analyses into device construction and their clinical implications.

Authors:  Ernest W Lau
Journal:  Pacing Clin Electrophysiol       Date:  2019-03-05       Impact factor: 1.976

4.  Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose?

Authors:  Philip Klein; Hedwig Blommestein; Maiwenn Al; Benedetta Pongiglione; Aleksandra Torbica; Saskia de Groot
Journal:  Health Econ       Date:  2022-08-21       Impact factor: 2.395

5.  Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden.

Authors:  Fredrik Gadler; Yao Ding; Nathalie Verin; Martin Bergius; Jeffrey D Miller; Gregory M Lenhart; Mason W Russell
Journal:  Clinicoecon Outcomes Res       Date:  2016-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.